About us

Our vision is a world where vaccine equity and health security are created for countries in all regions of the world. We aim to achieve this through the establishment of regional vaccine manufacturing and supply chain networks capable of producing vaccines for routine use in a sustainable manner, with readiness for outbreak manufacturing.

Our history

In 2022, RVMC was launched by the World Economic Forum (WEF), the US National Academies of Medicine (NAM), and the Coalition of Epidemic Preparedness Innovations (CEPI) to tackle the glaring inequities within the global vaccine production ecosystem revealed by the pandemic, especially impacting lower-to-middle income countries.

Initially incubated at WEF in partnership with Deloitte and co-chaired by US NAM and CEPI, RVMC’s first phase was dedicated to building a robust community of partners, fostering regional collaboration, and developing the RVMC Framework which outlines eight essential building blocks for a sustainable vaccine manufacturing ecosystem. RVMC also received support by international initiatives such as the Hiroshima G7 Global Health Task Force.

In January 2024, the founding parties announced the continuation of RVMC for the next three years with the backing of key partners, including regional bodies such as PAHO and Africa CDC. CEPI is now hosting the RVMC Secretariat and providing USD 15 million in funding.

During this second phase, RVMC aims to create value by advocating for regionalized manufacturing, aligning key initiatives, providing independent and trusted advice, and accounting for global progress across the RVMC Framework.

Who we are

RVMC Secretariat

Hosted at CEPI, the Secretariat is a small team focused on the day-to-day operations of RVMC. Dr. Frederik Kristensen leads the team as the inaugural Managing Director of RVMC.

Picture of man

Dr. Frederik Kristensen

Managing Director

Picture of man

Luigi Bonfatti

Executive Advisor

Picture of woman

Emmanuelle Naud

Senior Project Manager

Picture of woman

Holly Wingfield

Project Manager

Executive Committee

The Executive Committee is RVMC’s decision-making body. Its responsibilities include providing oversight on RVMC’s objectives, strategy, and work programs, and advising on key opportunities to achieve RVMC’s mission. 

Dr. Richard Hatchett

Dr. Richard Hatchett

CEO, Coalition for Epidemic Preparedness Innovations

Dr. Victor Dzau

Dr. Victor Dzau

President, US National Academy of Medicine

Dr. Shyam Bishen

Dr. Shyam Bishen

Head, Centre for Health and Healthcare, World Economic Forum

Farid Fezoua

Farid Fezoua

Global Director for Disruptive Technologies, Services, and Funds, International Finance Corp

H.E Dr. Jean Kaseya

H.E Dr. Jean Kaseya

Director-General, Africa Centres for Disease Control and Prevention

Dr. Jarbas Barbosa

Dr. Jarbas Barbosa

Director, Pan American Health Organization

Strategic Advisory Board (SAB)

The SAB advises the Executive Committee and Secretariat on RVMC’s strategic direction and potential areas of focus.

Catherine M. Russell

Catherine Russell

Executive Director, UNICEF

Daren Tang Heng Shim

Daren Tang Heng Shim

Director General, World Intellectual Property Organization

Dr. David Robinson

Dr. David Robinson

Deputy Director, Vaccine Development & Surveillance,  Bill and Melinda Gates Foundation

Dr. David Reddy

Dr. David Reddy

Director General, IFPMA

Farrah Losper

Farrah Losper

Chair, AVMI

Dr. Jerome Kim

Dr. Jerome Kim

Director General, IVI

Dr. John-Arne Røttingen

Dr. John-Arne Røttingen

CEO, Wellcome

Minister Ong Ye Kung

Minister Ong Ye Kung

Ministry of Health, Singapore

Rajinder Suri

Rajinder Suri

CEO, DCVMN

Minister Muhammad Ali Pate

Minister Muhammad Ali Pate

Ministry of Health, Nigeria

Dr. Sania Nishtar

Dr. Sania Nishtar

CEO, Gavi

Woman smiling

Anne Marie Mbengue Seye

Executive Director, Afrivac

Picture of man

Martin Seychell

Deputy Director General, INTPA, European Commission

Picture of woman

Dr. Yukiko Nakatani

Assistant Director General, WHO

Our regions of focus

Regions are best positioned to achieve the necessary scale of demand, investment, and capability for sustainable vaccine production. With equity and health security at the core of their thinking, regions have decided that they want to take greater control over the production and supply of vaccines to meet their needs.